1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AMGEN INC.
AMGEN Inc. XNAS: AMGN

AMGEN Inc. Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...

Read More
320.20 4.61 (1.46%)
Near 52W High of $335.88
2.7M
XNAS Volume

XNAS 07 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Dividend
AMGEN Inc. has an upcoming dividend of $2.38 per share due on 21 Nov 2025 See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Mid Valuation
42.8 / 100
Momentum Score
Technically Neutral
57.7 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
312
1Yr Price target downside is -2%
26 analysts

14

S

8

W

5

O

1

T

SWOT Analysis

Amgen Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..